News Release

Targeting Phage Therapy 2023: Many questions remain to be answered!

Meeting Announcement

Mitochondria-Microbiota Task Force

6th World Congress on Targeting Phage Therapy 2023

image: The 6th World Congress on Targeting Phage Therapy 2023 will be held on June 1-2, at IRIS, Paris, France. view more 

Credit: Credits to Targeting Phage Therapy Conference

The 6th World Congress on Targeting Phage Therapy 2023 will take place on June 1-2 at IRIS, Paris, France. 

Targeting Phage 2023: Questions, Controversies, and What is Next?

Targeting Phage Therapy 2023 will highlight the recent innovations and clinical applications of phages, validation and limitations. Targeting Phage Therapy 2023 will also cover how phages will transform the medicine of tomorrow.

International phage therapy and infectious disease experts will cover the following points:

  • Phage Therapy: A Glance Throughout the Years
  • Phage Therapy in Action: A Glimpse Within the Nations
  • Bacteriophages Today: Prophylactic & Therapeutic Potential
  • Phage Therapy: Towards Amplification and Innovation
  • Industrial Innovations – 10 Minutes to Convince

Access the full program.


More Than Just Scientific Knowledge at Targeting Phage Therapy 2023:

The regulation and legal aspects will also be debated and a kind of consensus will be elaborated at the end of the meeting. A discussion will also be held on how to overcome barriers between experts, academics, industrials, and regulators.

The chairman, Prof. Marvin Edeas, Institut Cochin, INSERM U1016, Université de Paris, stated: “Our aim is not to only gather speakers, but we must find an issue to bring phage therapy to another level. Each speaker will highlight where we are now and where we are heading. I believe that phages will be the hottest topic not only to combat infection and antibiotic resistance, but also to modulate our microbiota.”


International Speakers of Targeting Phage Therapy 2023

Targeting Phage Therapy 2023 will gather a group of academic and industrial professionals worldwide to discuss their most recent research and data.

Academic Speakers:

Domenico Frezza, University of Roma Tor Vergata, Italy

Phage Therapy: Vision and Gaps

Martha Clokie, University of Leicester, United Kingdom

Phage Therapy & Its Applications: Where We Are Now and What’s Next?

William Summers, Yale University, USA

 Historical Reflections of the Trials and Tribulations of Phage Therapy: 1930-1950

Tristan Ferry, Hospices Civils de Lyon, France

The Use of Bacteriophage Therapy for Complex Bacterial Infections: the PHAGEinLYON Experience

Anna Pistocchi, Università degli Studi di Milano, Italy

Investigating the Therapeutic Potential of Phages as Antibacterials and Immunomodulators in a Zebrafish Model of Cystic Fibrosis

Rodrigo Ibarra Chavez, University of Copenhagen, Denmark

Phage-inducible Chromosomal Islands Promote Genetic Variability by Blocking Phage Reproduction

Lilian Musila, U.S. Army Medical Research Directorate, Kenya

Potential of Therapeutic Phages to Combat MDR ESKAPE Pathogens in Developing Nations

Jean-Paul Pirnay, Queen Astrid Military Hospital, Belgium

Bacteriophages: It’s a medicine, Jim, but not as we know it

Aleksandra Petrovic Fabijan, Westmead Institute for Medical Research, Australia

Therapeutic Monitoring of Phage Therapy

Noemi Poerio, University of Rome Tor Vergata, Italy

A Novel Combined Host- and Pathogen-Directed Therapeutic Approach to Fight Infections by MDR- Klebsiella pneumoniae

Ryszard Międzybrodzki, Hirszfeld Institute of Immunology and Experimental Therapy PAS, Poland

Phages in the Medical Research Activity in Poland

Anders S. Nilsson, Stockholm University, Sweden

Novel Computer Program for Modelling Bacteriophage Infection Kinetics

Jolien Onsea, KU Leuven, Belgium

The Use of Bacteriophage Therapy for Difficult-to-Treat Musculoskeletal Infections: the PHAGEFORCE Experience

Mzia Kutateladze, Eliava Institute of Bacteriophage, Georgia

Phage Therapy: History in the Soviet Unions and Potential Treatment of Human Infections


Alexander Sulakvelidze, President and CEO of Intralytix, Inc., USA

Modern Approaches for Optimizing Therapeutic Phage Preparations

Jessica Sacher, cofounder of Phage Directory, Australia

Scaling Phage Therapy, Starting with Phage Australia

David Jernigan, PhagenCorp, LLC, USA

Inducing Native Phages From the Human Virome to Address Targeted Infections

Pranav Johri, Founder of Vitalis Phage Therapy, India

From Patient to Advocate – Introducing Phage Therapy to India

Farzaneh Moghtader, SET Medikal/NanoBMT, Turkey

Combined Therapies of Wound Infections with Phages/MSCs Aggregates


10 Minutes to Convince: Abstracts and Innovations

The 6th World Conference on Targeting Phage Therapy provides you with an opportunity to share your latest research or innovation in the field of phages and phage therapy.

Academics, industrialists, and startups representatives can present their latest innovation/ research in 10 minutes.


About Targeting Phage Therapy

This meeting is organized under the endorsement of the International Society of Microbiota (ISM). A session will be dedicated to how phage will modulate the quality and quantity of microbiota. Adequate phage selection to target microbiota dysbiosis in disease will also be covered.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.